Thian Bernard Yi Zhe, Fatimah Mohd Nasir Nurul, Wong Chuan Loo, Ong Hui Kian, Mariatulqabtiah Abdul Razak, Ho Kok Lian, Omar Abdul Rahman, Tan Wen Siang
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400, UPM Serdang, Selangor, Malaysia.
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400, UPM Serdang, Selangor, Malaysia; School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia.
Dev Comp Immunol. 2025 Jan;162:105275. doi: 10.1016/j.dci.2024.105275. Epub 2024 Sep 26.
Avian influenza A viruses (IAVs) pose a persistent threat to poultry industry worldwide, despite the presence of vaccines. Additionally, reverse-zoonosis transmission potentially introduces human-originated IAVs into poultry and complicates the efforts to control the spread of influenza. Current avian influenza vaccines are primarily based upon the rapidly mutating hemagglutinin (HA) and neuraminidase (NA) glycoproteins, which limit their efficacy against diverse strains of IAVs. Hence, the highly conserved ectodomains of matrix 2 protein (M2e) of IAVs are widely studied as alternatives to the HA and NA. However, the differences in the M2e amino acid sequences between avian and human IAVs generate antibodies that do not cross-react reciprocally with IAVs from other origins. To broaden and enhance the immunogenicity of M2e, we fused two copies each of the M2e derived from avian and human IAVs at the C-terminal end of the Macrobrachium rosenbergii nodavirus (MrNV) capsid protein (NvC). Transmission electron microscopic and dynamic light scattering analyses revealed that the chimeric protein self-assembled into virus-like particles (VLPs). Immunization of chickens with the chimeric VLPs demonstrated a robust induction of broadly reactive immune responses against both the M2e of avian and human IAVs. Additionally, the chimeric VLPs elicited the production of cytotoxic T lymphocytes (CTL), macrophages, as well as a well-balanced Th1 and Th2 population, indicating their potential in activating cell-mediated immune responses in chickens. Furthermore, the chimeric VLPs triggered the production of both Th1- and Th2-cytokines, attesting their potential in mounting a robust and balanced immune response in avian species. This study demonstrated the potential of these chimeric VLPs in stimulating and broadening cross-reactive immune responses in chickens against both avian and human IAVs.
尽管有疫苗存在,但甲型禽流感病毒(IAVs)仍对全球家禽业构成持续威胁。此外,反向人畜共患病传播有可能将源自人类的IAVs引入家禽群体,从而使控制流感传播的努力变得复杂。目前的禽流感疫苗主要基于快速变异的血凝素(HA)和神经氨酸酶(NA)糖蛋白,这限制了它们对多种IAV毒株的效力。因此,IAVs的基质2蛋白(M2e)高度保守的胞外域作为HA和NA的替代物受到广泛研究。然而,可以产生不能与其他来源的IAVs相互交叉反应的抗体的禽源和人源IAVs之间的M2e氨基酸序列存在差异。为了拓宽和增强M2e的免疫原性,我们在罗氏沼虾诺达病毒(MrNV)衣壳蛋白(NvC)的C末端融合了来自禽源和人源IAVs的两个拷贝的M2e。透射电子显微镜和动态光散射分析表明,嵌合蛋白自组装成病毒样颗粒(VLPs)。用嵌合VLPs免疫鸡显示出对禽源和人源IAVs的M2e均有强大的广泛反应性免疫应答诱导作用。此外,嵌合VLPs引发了细胞毒性T淋巴细胞(CTL)、巨噬细胞的产生,以及平衡良好的Th1和Th_{2}群体,表明它们在激活鸡的细胞介导免疫应答方面的潜力。此外,嵌合VLPs触发了Th1和Th2细胞因子的产生,证明了它们在禽类中引发强大且平衡的免疫应答的潜力。本研究证明了这些嵌合VLPs在刺激和拓宽鸡对禽源和人源IAVs的交叉反应性免疫应答方面的潜力。